{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:44:06Z","timestamp":1791290646236,"version":"4.3.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170278"],"award-info":[{"award-number":["82170278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1908205"],"award-info":[{"award-number":["U1908205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.biopha.2023.114569","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T15:35:12Z","timestamp":1680104112000},"page":"114569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["LCZ696 (sacubitril\/valsartan) inhibits pulmonary hypertension induced right ventricular remodeling by targeting pyruvate dehydrogenase kinase 4"],"prefix":"10.1016","volume":"162","author":[{"given":"Mengjia","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cankun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairuo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangjun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Bin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiping","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.biopha.2023.114569_bib1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.107.653584","article-title":"Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure","volume":"117","author":"Haddad","year":"2008","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.biopha.2023.114569_bib2","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","article-title":"Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy","volume":"58","author":"van de Veerdonk","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2023.114569_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.healun.2007.01.035","article-title":"Management of pulmonary arterial hypertension with a focus on combination therapies","volume":"26","author":"Benza","year":"2007","journal-title":"J. Heart Lung Transpl."},{"issue":"3","key":"10.1016\/j.biopha.2023.114569_bib4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1183\/09031936.00057010","article-title":"Pulmonary arterial hypertension, survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension","volume":"36","author":"Humbert","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.biopha.2023.114569_bib5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1378\/chest.15-0300","article-title":"Five-Year outcomes of patients enrolled in the REVEAL Registry","volume":"148","author":"Farber","year":"2015","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.biopha.2023.114569_bib6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1164\/rccm.202009-3698OC","article-title":"Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension","volume":"204","author":"Boucly","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"14","key":"10.1016\/j.biopha.2023.114569_bib7","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.117.032285","article-title":"Renin-angiotensin-aldosterone system inhibitors for right ventricular dysfunction in tetralogy of fallot: Quo Vadis","volume":"137","author":"Reddy","year":"2018","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.biopha.2023.114569_bib8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"P.-H. Investigators, committees, angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.114569_bib9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"P.-H. Investigators, angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N. Engl. J. Med"},{"issue":"6","key":"10.1016\/j.biopha.2023.114569_bib10","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"Writing","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"36","key":"10.1016\/j.biopha.2023.114569_bib11","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"issue":"13","key":"10.1016\/j.biopha.2023.114569_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015708","article-title":"Angiotensin receptor\u2010neprilysin inhibition attenuates right ventricular remodeling in pulmonary hypertension","volume":"9","author":"Sharifi Kia","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"21","key":"10.1016\/j.biopha.2023.114569_bib13","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1136\/heartjnl-2020-318074","article-title":"Sacubitril\/valsartan in the treatment of systemic right ventricular failure","volume":"107","author":"Zandstra","year":"2021","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.biopha.2023.114569_bib14","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.18632\/aging.202385","article-title":"RNA interactions in right ventricular dysfunction induced type II cardiorenal syndrome","volume":"13","author":"Chen","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.biopha.2023.114569_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jacbts.2017.08.001","article-title":"Cardioprotective effects of LCZ696 (Sacubitril\/Valsartan) after experimental acute myocardial infarction","volume":"2","author":"Ishii","year":"2017","journal-title":"JACC Basic Transl. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2023.114569_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ejhf.474","article-title":"LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice","volume":"18","author":"Suematsu","year":"2016","journal-title":"Eur. J. Heart Fail"},{"issue":"23","key":"10.1016\/j.biopha.2023.114569_bib17","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/CIRCULATIONAHA.120.047000","article-title":"Antihypertrophic memory after regression of exercise-induced physiological myocardial hypertrophy is mediated by the long noncoding RNA Mhrt779","volume":"143","author":"Lin","year":"2021","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.biopha.2023.114569_bib18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.115.016382","article-title":"Downregulation of microRNA-126 contributes to the failing right ventricle in pulmonary arterial hypertension","volume":"132","author":"Potus","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.114569_bib19","article-title":"Circ-Ddx60 contributes to the antihypertrophic memory of exercise hypertrophic preconditioning","author":"Zhu","year":"2022","journal-title":"J. Adv. Res."},{"issue":"5","key":"10.1016\/j.biopha.2023.114569_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"15","key":"10.1016\/j.biopha.2023.114569_bib21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/CIRCULATIONAHA.120.047626","article-title":"Identification of long noncoding RNA H19 as a new biomarker and therapeutic target in right ventricular failure in pulmonary arterial hypertension","volume":"142","author":"Omura","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.114569_bib22","article-title":"CX3CL1 worsens cardiorenal dysfunction and serves as a therapeutic target of canagliflozin for cardiorenal syndrome","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2023.114569_bib23","doi-asserted-by":"crossref","first-page":"H1103","DOI":"10.1152\/ajpheart.00636.2012","article-title":"ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4","volume":"304","author":"Mori","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114569_bib24","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0735-1097(00)00856-1","article-title":"Dichloroacetate improves postischemic function of hypertrophied rat hearts","volume":"36","author":"Wambolt","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9372","key":"10.1016\/j.biopha.2023.114569_bib25","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(03)13501-5","article-title":"Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study","volume":"361","author":"Jong","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.114569_bib26","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","author":"Humbert","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.biopha.2023.114569_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.109.927988","article-title":"Enalapril in infants with single ventricle: results of a multicenter randomized trial","volume":"122","author":"Hsu","year":"2010","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.biopha.2023.114569_bib28","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/heartjnl-2020-318787","article-title":"Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle","volume":"107","author":"Ladouceur","year":"2021","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.biopha.2023.114569_bib29","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","article-title":"Carvedilol for children and adolescents with heart failure: a randomized controlled trial","volume":"298","author":"Shaddy","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biopha.2023.114569_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.114.001785","article-title":"Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy","volume":"8","author":"von Lueder","year":"2015","journal-title":"Circ. Heart Fail"},{"issue":"11","key":"10.1016\/j.biopha.2023.114569_bib31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jama.2019.12662","article-title":"Angiotensin Receptor-Neprilysin Inhibition (ARNI) therapy and reverse remodeling in heart failure with reduced ejection fraction","volume":"322","author":"Drazner","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.biopha.2023.114569_bib32","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jcmg.2022.03.019","article-title":"Reverse remodeling assessed by left atrial and ventricular strain reflects treatment response to sacubitril\/valsartan","volume":"15","author":"Moon","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.biopha.2023.114569_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.005819","article-title":"Treatment of pulmonary hypertension with angiotensin II receptor blocker and neprilysin inhibitor sacubitril\/valsartan","volume":"12","author":"Clements","year":"2019","journal-title":"Circ. Heart Fail"},{"issue":"5","key":"10.1016\/j.biopha.2023.114569_bib34","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/cvr\/cvaa200","article-title":"Additive protective effects of sacubitril\/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension","volume":"117","author":"Chaumais","year":"2021","journal-title":"Cardiovasc Res."},{"issue":"9","key":"10.1016\/j.biopha.2023.114569_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024449","article-title":"Effect of Sacubitril\/Valsartan on the right ventricular function and pulmonary hypertension in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of observational studies","volume":"11","author":"Zhang","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.biopha.2023.114569_bib36","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/ehf2.13952","article-title":"Sacubitril\/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension","volume":"9","author":"Codina","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.biopha.2023.114569_bib37","article-title":"A study of the efficacy of sacubitril\/valsartan plus dapagliflozin combination treatment in pulmonary arterial hypertension due to left heart disease","author":"Ge","year":"2022","journal-title":"Perfusion"},{"issue":"4","key":"10.1016\/j.biopha.2023.114569_bib38","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.biopha.2023.114569_bib39","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.healun.2021.06.020","article-title":"Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"40","author":"Benza","year":"2021","journal-title":"J. Heart Lung Transpl."},{"issue":"20","key":"10.1016\/j.biopha.2023.114569_bib40","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med"},{"issue":"12","key":"10.1016\/j.biopha.2023.114569_bib41","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/CIRCRESAHA.117.311456","article-title":"PDK4 inhibits cardiac pyruvate oxidation in late pregnancy","volume":"121","author":"Liu","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2023.114569_bib42","doi-asserted-by":"crossref","first-page":"4532592","DOI":"10.1155\/2019\/4532592","article-title":"Adaptations in protein expression and regulated activity of pyruvate dehydrogenase multienzyme complex in human systolic heart failure","volume":"2019","author":"Sheeran","year":"2019","journal-title":"Oxid. Med Cell Longev."},{"issue":"17","key":"10.1016\/j.biopha.2023.114569_bib43","doi-asserted-by":"crossref","first-page":"17464","DOI":"10.1074\/jbc.M414220200","article-title":"Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy","volume":"280","author":"Planavila","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114569_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.602100","article-title":"Variations in energy metabolism precede alterations in cardiac structure and function in hypertrophic preconditioning","volume":"7","author":"Wu","year":"2020","journal-title":"Front Cardiovasc Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.114569_bib45","doi-asserted-by":"crossref","first-page":"H936","DOI":"10.1152\/ajpheart.00870.2007","article-title":"Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy","volume":"294","author":"Zhao","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2023.114569_bib46","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.metabol.2013.06.013","article-title":"Alteration of cardiac glucose metabolism in association to low birth weight: experimental evidence in lambs with left ventricular hypertrophy","volume":"62","author":"Wang","year":"2013","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.biopha.2023.114569_bib47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00109-012-0982-0","article-title":"FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate","volume":"91","author":"Piao","year":"2013","journal-title":"J. Mol. Med. (Berl. )"},{"issue":"1","key":"10.1016\/j.biopha.2023.114569_bib48","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.1152\/ajpendo.00452.2015","article-title":"Age-related impairments in skeletal muscle PDH phosphorylation and plasma lactate are indicative of metabolic inflexibility and the effects of exercise training","volume":"311","author":"Consitt","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2023.114569_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gpb.2015.03.006","article-title":"Regulation of the PI3K\/AKT pathway and fuel utilization during primate torpor in the gray mouse lemur, microcebus murinus","volume":"13","author":"Tessier","year":"2015","journal-title":"Genom. Proteom. Bioinforma."},{"issue":"1","key":"10.1016\/j.biopha.2023.114569_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/cvr\/cvz016","article-title":"Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of beta-catenin","volume":"116","author":"Lin","year":"2020","journal-title":"Cardiovasc Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223003578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223003578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:26:58Z","timestamp":1778246818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223003578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":50,"alternative-id":["S0753332223003578"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114569","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LCZ696 (sacubitril\/valsartan) inhibits pulmonary hypertension induced right ventricular remodeling by targeting pyruvate dehydrogenase kinase 4","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114569"}}